Literature DB >> 33722723

The Third Eye Sees Double: Cohort Study of Clinical Presentation, Histology, Surgical Approaches, and Ophthalmic Outcomes in Pineal Region Germ Cell Tumors.

Hirokazu Takami1, Christopher S Graffeo1, Avital Perry1, Caterina Giannini2, David J Daniels3.   

Abstract

BACKGROUND: Intracranial germ cell tumors (GCTs) predominantly occur in the adolescent and young adult population and are most frequently located at the pineal gland. Tumor masses in the pineal region may cause ophthalmic symptoms due to compression to the midbrain, frequently presenting with Parinaud syndrome and hydrocephalus due to aqueductal compression.
METHODS: We conducted a single-institution cohort study of primary, pineal region GCTs to characterize the clinical presentation, as well as associated ophthalmic and hydrocephalus outcomes.
RESULTS: Fifty-six primary pineal GCTs were identified. Among the 40 isolated pineal region GCTs, 15 were germinomas while 25 were nongerminomatous GCTs. Among 43 cases of hydrocephalus, endoscopic third ventriculostomy was the primary treatment in 27 cases, which was successful in 23 but failed and required additional treatment for the rest. Pineal tumor mass was significantly larger in cases with hydrocephalus compared with those without, and the 20-mm diameter of the tumor was the crucial point for obstructive hydrocephalus. Ophthalmic symptoms were commonly observed at presentation, which included diplopia (74.3%), upward-gaze palsy (69.7%), and Argyll Robertson pupil (40%). These symptoms tended to remain, and the existence of these symptoms at presentation predicted the remaining symptoms in the follow-up.
CONCLUSIONS: Intracranial GCTs presenting with ophthalmic abnormalities appear to be at increased risk of residual posttreatment symptoms, while second-look surgery presents a significant risk factor for the development of new deficits. Hydrocephalus often accompanies pineal region GCTs, and in most cases both cerebrospinal fluid diversion and tissue diagnosis can be successfully achieved via endoscopic third ventriculostomy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopic third ventriculostomy; Germ cell tumor; Germinoma; Hydrocephalus; Neuroophthalmology; Pineal gland

Year:  2021        PMID: 33722723     DOI: 10.1016/j.wneu.2021.03.030

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Results of the treatment of pineal tumors in children: the Lyon experience.

Authors:  Alexandru Szathmari; Pierre-Aurélien Beuriat; Alexandre Vasiljevic; Pierre Leblond; Cécile Faure-Conter; Line Claude; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2022-10-15       Impact factor: 1.532

2.  The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.

Authors:  Hideo Nakamura; Hirokazu Takami; Takaaki Yanagisawa; Toshihiro Kumabe; Takamitsu Fujimaki; Yoshiki Arakawa; Katsuyuki Karasawa; Keita Terashima; Hideaki Yokoo; Kohei Fukuoka; Yukihiko Sonoda; Kaori Sakurada; Yohei Mineharu; Toshinori Soejima; Motoaki Fujii; Naoki Shinojima; Junichi Hara; Kai Yamasaki; Junya Fujimura; Fumiyuki Yamasaki; Mayu Takahashi; Tomonari Suzuki; Iori Sato; Ryo Nishikawa; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

3.  Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort.

Authors:  Hirokazu Takami; Christopher S Graffeo; Avital Perry; Caterina Giannini; Yoichi Nakazato; Nobuhito Saito; Masao Matsutani; Ryo Nishikawa; Koichi Ichimura; David J Daniels
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.